ConductScience.org, home

Trial · NCT00581893

Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study

NCT00581893, Phase 4, Completed, University of Iowa; results first posted 2021-07-01

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study. Trials, record NCT00581893. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00581893

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study
NCT number
NCT00581893
Status
Completed
Phases
Phase 4
Enrollment
20 participants, actual
Lead sponsor
University of Iowa
Conditions
Cognitive Measures, Driving Simulator Performance
Interventions
Phenytoin, Placebo oral capsule
First posted
2007-12-28
Last updated
2021-07-01
Results first posted
2021-07-01
Limitations and caveats
The very small sample size of evaluable subjects prevents definitive conclusions on the safety hazards of phenytoin for driving performance.

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Subjects Who Had a Driving Simulator Crash Event1 monthNumber of subjects who had a crash event during the driving simulator test.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Subjects Who Had a Driving Simulator Crash Event1 monthParticipantsCOUNT_OF_PARTICIPANTS

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Subjects Who Had a Driving Simulator Crash EventPhenytoin2Participants
Number of Subjects Who Had a Driving Simulator Crash EventPlacebo0Participants

Participant flow18

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
First Intervention (1 Month)STARTEDPhenytoin First, Then Placebo10
First Intervention (1 Month)STARTEDPlacebo First, Then Phentoin10
First Intervention (1 Month)COMPLETEDPhenytoin First, Then Placebo10
First Intervention (1 Month)COMPLETEDPlacebo First, Then Phentoin10
First Intervention (1 Month)NOT COMPLETEDPhenytoin First, Then Placebo0
First Intervention (1 Month)NOT COMPLETEDPlacebo First, Then Phentoin0
Washout (14 Days)STARTEDPhenytoin First, Then Placebo10
Washout (14 Days)STARTEDPlacebo First, Then Phentoin10
Washout (14 Days)COMPLETEDPhenytoin First, Then Placebo10
Washout (14 Days)COMPLETEDPlacebo First, Then Phentoin10

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityPhenytoin020
Total, all-cause mortalityPlacebo020
Total, other adverse eventsPhenytoin020
Total, other adverse eventsPlacebo020
Total, serious adverse eventsPhenytoin020
Total, serious adverse eventsPlacebo020

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R49CE721682Grant for Injury control research centerPEEK-ASA, CORINNEUNIVERSITY OF IOWANATIONAL CENTER FOR INJURY PREVENTION AND CONTROL2005 to 2006

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Phenytoin vs Placebo: Number of Subjects Who Had a Driving Simulator Crash EventTrial comparisons
Phenytoin vs Placebo: deaths from any causeTrial comparisons
Phenytoin vs Placebo: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00581893

GET https://conductscience.org/api/trials/v1/NCT00581893/registered